Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Discoveries Point to More Powerful Cancer Treatments, Fewer Side Effects

28.02.2014

Rutgers research suggests chemo and radiation can kill more cancer cells and spare healthy ones

What if there were a way to make chemotherapy and radiation more effective as cancer treatments than they are today, while also getting rid of debilitating side effects that patients dread? A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Wood Johnson Medical School and member of the Rutgers Cancer Institute of New Jersey, suggests the day that happens could be getting closer.

Side effects such as heart damage, nausea and hair loss occur when cancer therapy kills healthy cells along with the malignant cells that are being targeted. It is a medical form of collateral damage. But Ryazanov explains that if a way could be found to protect those healthy cells, then doses of chemo and radiation could actually be increased, “killing all the cancer cells and the patient would be cured. We also could start treating cancers that now can’t be cured because the most effective doses are too toxic to normal tissues.”

The key to Ryazanov’s vision of cancer treatment is addition by subtraction – specifically elimination of eEF2K – an enzyme that influences the rates at which proteins are created in the human body. Ryazanov first identified eEF2K more than a quarter century ago, and since then, bit by bit, he and other scientists have uncovered many complicated processes for which that enzyme is responsible.

Ryazanov’s latest findings, published in the journal Developmental Cell, demonstrate that the presence of eEF2K weakens healthy cells. His evidence is the enzyme’s involvement in a process where defective cells involved in reproduction are degraded – and ultimately destroyed – as a way to preserve genetic quality from one generation to the next.

There is eEF2K in every cell in the body, and Ryazanov says the enzyme’s presence tends to leave cells less robust than they otherwise would be. According to Ryazanov, it is that added weakness that leaves healthy cells vulnerable to being poisoned by chemo and radiation.

Ryazanov says removing the enzyme would make those healthy cells stronger, to the point where they would survive cancer therapy. That, in turn, would eliminate the side effects.

How would healthy cells survive cancer treatment while malignant cells would not? Ryazanov explains that tumors grow and cancer spreads when malignant cells divide and duplicate. Chemo and radiation are specifically designed to block cell division, and Ryazanov says removing the enzyme eEF2K actually makes the cancer cells more vulnerable to the treatment. By contrast, as long as healthy cells are strong enough to resist being poisoned, the cancer therapies won’t hurt them.

In 2008, Ryazanov founded Longevica Pharmaceuticals, a company whose mission is to perfect medications designed to eliminate the enzyme and improve the performance of chemo and radiation. Animal testing is already underway, and Ryazanov hopes that his new findings will speed the day when medications that pass those tests can be tried in people. He even predicts that taking such a drug may be as easy as swallowing a pill.

Ryazanov says there is a nice logic to the research and drug development that have become his life’s work – because the cancer therapies he wants to enhance already exist and are known to work. Making chemo and radiation less toxic, he says, can make those therapies dramatically more effective in the relatively near future, while other cutting-edge approaches to cancer treatment might need far more time to prove their ultimate worth.

Rob Forman | newswise
Further information:
http://www.rutgers.edu

Further reports about: Biomedical Cancer Powerful Rutgers damage eEF2K effects enzyme healthy malignant therapy

More articles from Life Sciences:

nachricht Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs
16.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Cholera bacteria infect more effectively with a simple twist of shape
13.01.2017 | Princeton University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>